Supriya Lifescience files DRHP with SEBI for Rs 1,200 crore IPO

17 May 2021 Evaluate

Supriya Lifescience has filed draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) to raise Rs 1,200 crore through an initial public offering (IPO).  

Proceeds from the fresh issue will be used for funding capital expenditure requirements, repay debt and general corporate purpose. ICICI Securities and Axis Capital have been appointed as merchant bankers to advise the company on the IPO.

Supriya Lifescience is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development.

Supriya Lifescience Share Price

637.70 13.85 (2.22%)
01-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.